A Phase 1 Study of Two Enterotoxigenic Escherichia Coli Prototype Adhesin-Based Vaccines With or Without Modified Heat-labile Enterotoxin by Intradermal or Transcutaneous Immunization

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 18 Sep 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs FimH adhesin vaccine (Primary) ; FimH adhesin vaccine (Primary) ; LT R192G; LT R192G
Indications Bacterial infections; Diarrhoea
Focus Adverse reactions

12 Feb 2021 Biomarkers information updated
08 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
09 Aug 2012 Actual initiation date (Aug 2012) added as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com